To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
To provide an IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant or cellular therapies for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach. To provide a consent mechanism for the retrospective study of cellular products, when available, if there is a specific question to be addressed.
Study Type
OBSERVATIONAL
Enrollment
2,000
Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
RECRUITINGData followup
Gather basic survival and complication data for operational and research databases for ongoing regulatory and future operational queries
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.